Canaccord Genuity Boosts Intra-Cellular Therapies (NASDAQ:ITCI) Price Target to $65.00

 

Canaccord Genuity Boosts Intra-Cellular Therapies (NASDAQ:ITCI) Price Target to $65.00

Recommended Story: Trading Penny Stocks Receive News & Ratings for Intra-Cellular Therapies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ …

More Canaccord Genuity Boosts Intra-Cellular Therapies (NASDAQ:ITCI) Price Target to $65.00 Videos

Leave a Reply